Form EFFECT Theriva Biologics, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 2, 2025 9:00 A.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ANTHONY J. COHEN FILES EARLY WARNING REPORT IN CONNECTION WITH HOLDINGS OF COMMON SHARES OF PLATO GOLD CORP.
- Nyangumarta Warrarn Aboriginal Corporation and Rio Tinto sign milestone agreement for Winu Project
- Houston Couple Brings a Personal Approach to Recovery and Wellness to the Energy Corridor with New beem® Studio
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
